• About Us

    • Overview
    • Leadership
    • R&D Team
    • Board
    • Scientific Advisors
    • Partners
    • Investors
  • Infertility

    • Overview
    • Infertility in Women
    • Infertility in Men
  • Our Science

    • Overview
    • IGYX12
    • Publications
  • Newsroom

    • Latest News
    • Media Inquiries
  • Careers

    • Join the Team
    • Open Positions
    • Submit Your Resume
  • Contact

    • General Inquiries
  • More

    Use tab to navigate through the menu items.
     
    header4.jpg

    Newsroom: Latest News

    Latest News
    Media Inquiries

    22

    Igyxos selected for the French Tech 120 (FT120) program for the third consecutive year

    APR25

    2022

    21

    Igyxos pursues its development and appoints Thierry Ziegler as CMC Chief Operating Officer

    MAR15

    2021

    20

    Igyxos and Selexis enter service agreement to advance Igyxos’ first-in-class monoclonal antibody for the treatment of human infertility

    SEP02

    2020

    19

    Igyxos raises €7.5 million to finance the preclinical and clinical development of its drug candidate First-In-Class in the treatment of human infertility

    MAR21

    2019

    About Us
    Board of Directors
    Scientific Advisors
    Partners
    Overview
    Leadership
    R&D Team
    Investors
    Infertility
    Overview
    Infertility in Women
    Infertility in Men
    Our Science
    Overview
    IGYX12
    Publications
    Newsroom
    Latest News
    Media Inquiries
    Careers
    Join the Team
    Open Positions
    Submit Your Resume

    IGYXOS S.A.
    Centre INRA Val de Loire
    Site de Tours
    37380 Nouzilly, France
    Tel:
    + 33 2 47 42 79 57

    Contact
    General Inquiries
    Terms of Use
    Conditions d’utilisation
    Privacy
    Politique de Confidentialite

    This site was last updated on March 24 at 3:30pm EST.
    © 2022 Igyxos, Inc. All rights reserved.